Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 108 clinical trials
featured
Are you undergoing treatment for Congestive Heart Failure?

Are you undergoing treatment for Congestive Heart Failure?

  • 610 views
  • 08 Nov, 2020
  • 1 location
featured
Patients with Heart Failure and currently on a loop diuretic

The purpose of this study is to evaluate the action of the study drug on your kidneys and your ability to eliminate salt and water alongside a diuretic (furosemide). The information gathered during this clinical trial may support further drug development, including larger trials in patients with heart failure.  The study …

fatigue
furosemide
heart failure
  • 88 views
  • 23 Nov, 2020
  • 1 location
ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD)

the combination of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) and calcium antagonists (CCB) or thiazide diuretics (DIU). However, whether the two

systolic blood pressure
ambulatory blood pressure monitoring
angiotensin converting enzyme
blood pressure diastolic
thiazide
  • 8 views
  • 08 Nov, 2020
  • 1 location
Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia

Hyperkalemia is a common electrolyte disorder, especially among patients with chronic kidney disease, diabetes mellitus, or heart failure. Globally, the reported incidence of hyperkalemia varies from 1.1 to 10 per 100 hospitalizations, depending on the patient cohort and comorbidities. Hyperkalemia is a potentially life-threatening electrolyte disturbance that can be fatal …

  • 1 views
  • 17 Jan, 2021
  • 14 locations
Controlled Fluid Removal in Critical Ill Patients With Fluid Overload in the Intensive Care Unit.

This study evaluates the benefits and harms of goal directed fluid removal with furosemide versus placebo in critical ill adult patients with fluid overload in the intensive care unit. Half of the patients will receive furosemide and the other half placebo. The treatment will continue until the excess fluid is …

edema
furosemide
norepinephrine
  • 0 views
  • 26 Aug, 2020
  • 8 locations
Digoxin Short Term Treatment Assessment Randomized Trial in AHF

AHFS management is challenging and most of the used drugs has failed to decrease post-discharge mortality and readmission rates which represent the most important goal in AHFS. Digoxin processes many characteristics of a beneficial drug for heart failure, however recent publications has rose concerns about its safety profile and therefore …

  • 3 views
  • 17 Feb, 2020
  • 2 locations
The Effect of Antihypertensive Medication Timing on Morbidity and Mortality

High blood pressure is common and its presence increases the risk of cardiovascular mortality and morbidity (most notably stroke, myocardial infarction, and congestive heart failure). Given blood pressure is normally higher during the day than it is overnight, blood pressure lowering medications are traditionally taken in the morning. However a …

antihypertensive drugs
cardiovascular morbidity
myocardial infarction
stroke
  • 39 views
  • 25 Nov, 2019
  • 2 locations
Pilot Study of Loop Diuretics Among Individuals Receiving Hemodialysis

contributors to cardiovascular complications. Reversing volume overload has been shown to improve blood pressure and cardiac remodeling. Use of loop diuretics may represent a pragmatic, low-cost, and low

  • 0 views
  • 17 Nov, 2020
  • 5 locations
Use of Diuretics in Maintenance Hemodialysis Patients Undergoing Bioimpedance-guided Fluid Management

Background.The objective of the present study is to verify whether using diuretics will improve either blood pressure or fluid overload in maintenance hemodialysis patients with residual

  • 1 views
  • 08 Dec, 2019
  • 1 location
Oral dIuretics in Very Intensive Treatment an Early Intervention in Outpatients With Heart Failure

In the present study, consecutive patients, older than 18 years, of both genders will be included. The diagnosis of reduced Heart Failure (HfrEF) according to: Clinical pattern, laboratories and Cardiac imaging (ESC criteria). Treatment will be assigned in two groups: Bumetanide and another group will be received Indapamide. Each group …

bumetanide
edema
b-type natriuretic peptide
ejection fraction
diuretics
  • 7 views
  • 08 Nov, 2020
  • 1 location